LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)

NCT00516087 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

BIOLOGICAL: Genetically modified CTLs

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]